retatrutide liver damage Patients in failure after using knock-off weight loss drug retatrutide nonalcoholic fatty liver disease

As a result, the dramatic improvements seen early in treatment often become less noticeable over time

They mimic the action of endogenous GLP-1, a hormone naturally released by cells in the small intestine in response to food intake and exert effects 16 (Figure 1) in a dose-dependent manner 17

Nausea is reported in 16 to 44 percent of semaglutide users, particularly during dose escalation phases

In a man with prostate cancer on androgendeprivation therapy who also has diabetes or obesity, should I continue or start a GLP1 receptor agonist, and what dosing and monitoring are recommended?

Reducing Inflammation Chronic inflammation damages hair follicles